Exploratory research on blood analytes sampled with minimally invasive blood sampling device OneDraw

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs052210065

Enrollment

Registered

2021-08-17

Start date

2021-09-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Blood collection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with diabetes

Exclusion criteria

Exclusion criteria: 1) Patients under anticoagulant therapy 2) Patients with known interference factors in HbA1c measurement

Design outcomes

Primary

Measure	Time frame
Correlation of seven analytes (HbA1c, LDL-chol, HDL-chol, TG, creatinine, ALT, and glucose) between whole blood obtained by novel blood collecting device and matched serum.	—

Secondary

Measure	Time frame
1) Time required for blood collection 2) Pain scale 3) Preference for two sampling methods	—

Contacts

Public ContactKaori Ikeda

Kyoto University Hospital

krikeda@kuhp.kyoto-u.ac.jp+81-75-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026